Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.
Kristi Martin, MPA, MA
Advertisement
https://www.commonwealthfund.org/person/kristi-martin
Articles by Kristi Martin, MPA, MA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
2
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD
5
